Western Wealth Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.07M Sell
31,663
-315
-1% -$36.9K 0.13% 153
2026
Q1
$3.85M Buy
31,978
+9,739
+44% +$1.12M 0.15% 138
2025
Q4
$2.34M Buy
22,239
+2,571
+13% +$241K 0.11% 192
2025
Q3
$1.65M Buy
19,668
+151
+0.8% +$12.4K 0.09% 217
2025
Q2
$1.55M Sell
19,517
-1,031
-5% -$82K 0.09% 207
2025
Q1
$1.84M Sell
20,548
-8,547
-29% -$798K 0.12% 171
2024
Q4
$2.89M Buy
29,095
+374
+1% +$38.6K 0.16% 130
2024
Q3
$3.26M Buy
28,721
+5,925
+26% +$704K 0.19% 108
2024
Q2
$2.82M Sell
22,796
-139
-0.6% -$17.9K 0.21% 93
2024
Q1
$3.03M Sell
22,935
-6,359
-22% -$784K 0.24% 85
2023
Q4
$3.19M Buy
29,294
+472
+2% +$49K 0.23% 88
2023
Q3
$2.97M Buy
28,822
+1,357
+5% +$146K 0.25% 80
2023
Q2
$3.17M Buy
27,465
+755
+3% +$85.7K 0.27% 79
2023
Q1
$2.84M Buy
26,710
+45
+0.2% +$4.86K 0.26% 86
2022
Q4
$2.96M Sell
26,665
-23,215
-47% -$2.37M 0.3% 77
2022
Q3
$4.38M Buy
49,880
+2,163
+5% +$193K 0.25% 91
2022
Q2
$4.36M Sell
47,717
-3,009
-6% -$267K 0.25% 89
2022
Q1
$4.16M Buy
50,726
+23,394
+86% +$1.84M 0.2% 106
2021
Q4
$2.1M Buy
+27,332
New +$2.18M 0.21% 112
2021
Q2
$2.11M Buy
27,145
+5,236
+24% +$389K 0.22% 106
2021
Q1
$1.61M Buy
21,909
+2,612
+14% +$193K 0.22% 108
2020
Q4
$1.51M Sell
19,297
-3,836
-17% -$293K 0.22% 108
2020
Q3
$1.83M Buy
23,133
+1,319
+6% +$103K 0.3% 81
2020
Q2
$1.61M Buy
21,814
+1,970
+10% +$148K 0.29% 81
2020
Q1
$1.46M Buy
19,844
+1,450
+8% +$114K 0.33% 73
2019
Q4
$1.6M Sell
18,394
-2,348
-11% -$193K 0.24% 96
2019
Q3
$1.67M Sell
20,742
-393
-2% -$31.5K 0.35% 66
2019
Q2
$1.69M Buy
21,135
+952
+5% +$72.9K 0.22% 92
2019
Q1
$1.6M Buy
20,183
+2,282
+13% +$171K 0.36% 69
2018
Q4
$1.3M Buy
+17,901
New +$1.26M 0.35% 68

Other funds holding MRK

Western Wealth Management's MRK Position: Q2 2026 in Review

Western Wealth Management reduced its Merck (MRK) stake by 0.99% in Q2 2026, selling an estimated $36.9K and leaving 31,663 shares worth $4.07M. The position accounts for 0.13% of the portfolio, ranked #153.

Western Wealth Management first reported a position in MRK in Q4 2018 and has held it in 30 quarters since. The position peaked at $4.38M in Q3 2022. 3,833 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Western Wealth Management held 31,663 shares of Merck worth $4.07M as of Q2 2026.
  • Western Wealth Management sold 315 Merck shares in Q2 2026, an estimated $36.9K.
  • Merck made up 0.13% of Western Wealth Management's portfolio in Q2 2026, its #153 holding.
  • Western Wealth Management first reported a position in Merck in Q4 2018 and has held it in 30 quarters since.
  • Western Wealth Management's Merck position peaked at $4.38M in Q3 2022.
  • 3,833 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Western Wealth Management's 13F filing for Q2 2026, filed 14 Aug 2026.